| Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation RCO Zanardo, V Brancaleone, E Distrutti, S Fiorucci, G Cirino, JL Wallace, ... The FASEB journal 20 (12), 2118-2120, 2006 | 1137 | 2006 |
| The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis S Fiorucci, E Antonelli, A Mencarelli, S Orlandi, B Renga, G Rizzo, ... Hepatology 42 (3), 539-548, 2005 | 649 | 2005 |
| The bile acid receptor FXR is a modulator of intestinal innate immunity P Vavassori, A Mencarelli, B Renga, E Distrutti, S Fiorucci The Journal of Immunology 183 (10), 6251-6261, 2009 | 644 | 2009 |
| Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs S Fiorucci, E Antonelli, E Distrutti, G Rizzo, A Mencarelli, S Orlandi, ... Gastroenterology 129 (4), 1210-1224, 2005 | 553 | 2005 |
| The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver S Fiorucci, E Distrutti, G Cirino, JL Wallace Gastroenterology 131 (1), 259-271, 2006 | 534 | 2006 |
| Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders S Fiorucci, E Distrutti Trends in molecular medicine 21 (11), 702-714, 2015 | 495 | 2015 |
| Bile acids activated receptors regulate innate immunity S Fiorucci, M Biagioli, A Zampella, E Distrutti Frontiers in immunology 9, 1853, 2018 | 458 | 2018 |
| Gut microbiota role in irritable bowel syndrome: New therapeutic strategies E Distrutti, L Monaldi, P Ricci, S Fiorucci World journal of gastroenterology 22 (7), 2219, 2016 | 422 | 2016 |
| The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis S Cipriani, A Mencarelli, MG Chini, E Distrutti, B Renga, G Bifulco, ... PloS one 6 (10), e25637, 2011 | 390 | 2011 |
| Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels E Distrutti, L Sediari, A Mencarelli, B Renga, S Orlandi, E Antonelli, ... Journal of Pharmacology and Experimental Therapeutics 316 (1), 325-335, 2006 | 341 | 2006 |
| Gastric wall tension determines perception of gastric distention E Distrutti, F Azpiroz, A Soldevilla, JR Malagelada Gastroenterology 116 (5), 1035-1042, 1999 | 270 | 1999 |
| Enhanced activity of a hydrogen sulphide‐releasing derivative of mesalamine (ATB‐429) in a mouse model of colitis S Fiorucci, S Orlandi, A Mencarelli, G Caliendo, V Santagada, E Distrutti, ... British journal of pharmacology 150 (8), 996-1002, 2007 | 267 | 2007 |
| Modulation of intestinal microbiota by the probiotic VSL# 3 resets brain gene expression and ameliorates the age-related deficit in LTP E Distrutti, JA O’Reilly, C McDonald, S Cipriani, B Renga, MA Lynch, ... PloS one 9 (9), e106503, 2014 | 255 | 2014 |
| Targeting farnesoid X receptor for liver and metabolic disorders S Fiorucci, G Rizzo, A Donini, E Distrutti, L Santucci Trends in molecular medicine 13 (7), 298-309, 2007 | 255 | 2007 |
| Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis S Fiorucci, A Mencarelli, B Palazzetti, E Distrutti, N Vergnolle, ... Proceedings of the National Academy of Sciences 98 (24), 13936-13941, 2001 | 251 | 2001 |
| Antiatherosclerotic effect of farnesoid X receptor A Mencarelli, B Renga, E Distrutti, S Fiorucci American Journal of Physiology-Heart and Circulatory Physiology 296 (2 …, 2009 | 218 | 2009 |
| PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation S Fiorucci, E Antonelli, E Distrutti, B Severino, R Fiorentina, M Baldoni, ... Hepatology 39 (2), 365-375, 2004 | 203 | 2004 |
| A β-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction S Fiorucci, JL Wallace, A Mencarelli, E Distrutti, G Rizzo, S Farneti, ... Proceedings of the National Academy of Sciences 101 (44), 15736-15741, 2004 | 195 | 2004 |
| Bile acids and their receptors in metabolic disorders S Fiorucci, E Distrutti, A Carino, A Zampella, M Biagioli Progress in Lipid Research 82, 101094, 2021 | 191 | 2021 |
| Bile acid signaling in inflammatory bowel diseases S Fiorucci, A Carino, M Baldoni, L Santucci, E Costanzi, L Graziosi, ... Digestive Diseases and Sciences 66, 674-693, 2021 | 183 | 2021 |
Stefano FiorucciUniversity of PerugiaПодтвержден адрес электронной почты в домене unipg.it
